ScholarLens Back to search
2003•Medical Journal of National Defending Forces in Northwest ChinaRequires access

Clinical study on matrine for the treatment of chronic hepatitis B

Chen Guan-pei

Open publisher page 2 citations

Abstract

Objective: To investigate the clinical effects of matrine on chronic viral hepatitis B. Methods:125 cases were divided into matrine group, matrine+IFN-α2b group and IFN-α2b group to observe the changes of HBV-M, HBV-DNA, ALT and AST. Results:After treatment for three months, the negative transforming rates of HBeAg and HBV-DNA were 30.4% and 39.1% in matrine group, 36.6% and 41.5% in IFN-α2b group, 39.5% and 50.0% in matrine+IFN-α2b group respectively, and the positive transforming rates of HBeAb were similar. After 12 months followup, the total effective rates were 12%, 9%, and 18% in matrine, IFN-α2b and matrine+IFN-α2b group respectively. Conclusion:Matrine and IFN-α2b are both effective in treating hepatitis B,combining of matrine and IFN-α2b could be more effective.

About this research paper

What this paper is about

Objective: To investigate the clinical effects of matrine on chronic viral hepatitis B. Methods:125 cases were divided into matrine group, matrine+IFN-α2b group and IFN-α2b group to observe the changes of HBV-M, HBV-DNA, ALT and AST. Results:After treatment for three months, the negative transforming rates of HBeAg and HBV-DNA were 30.4% and 39.1% in matrine group, 36.6% and 41.5% in IFN-α2b group, 39.5% and 50.0% in matrine+IFN-α2b group respectively, and the positive transforming rates of HBeAb were similar. After 12 months followup, the total effective rates were 12%, 9%, and 18% in matrine, IFN-α2b and matrine+IFN-α2b group respectively. Conclusion:Matrine and IFN-α2b are both effective in treating hepatitis B,combining of matrine and IFN-α2b could be more effective.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the clinical effects of matrine on chronic viral hepatitis B. Methods:125 cases were divided into matrine group, matrine+IFN-α2b group and IFN-α2b group to observe the changes of HBV-M, HBV-DNA, ALT and AST. Results:After treatment for three months, the negative transforming rates of HBeAg and HBV-DNA were 30.4% and 39.1% in matrine group, 36.6% and 41.5% in IFN-α2b group, 39.5% and 50.0% in matrine+IFN-α2b group respectively, and the positive transforming rates of HBeAb were similar. After 12 months followup, the total effective rates were 12%, 9%, and 18% in matrine, IFN-α2b and matrine+IFN-α2b group respectively. Conclusion:Matrine and IFN-α2b are both effective in treating hepatitis B,combining of matrine and IFN-α2b could be more effective.

Key concepts: Matrine, HBeAg, Medicine, Chronic hepatitis, Internal medicine, Gastroenterology, Group A, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical study on matrine for the treatment of chronic hepatitis B — Research Paper | ScholarLens